Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9153179 | American Heart Journal | 2005 | 7 Pages |
Abstract
For most patients at high risk after MI, the availability of generic captopril confers a cost advantage over valsartan because of lower medication costs. The difference will be smaller or nonexistent in settings where brand-name ACE inhibitors are prescribed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shelby D. PhD, Jasmina I. MA, Kevin P. PhD, John J.V. MD, Marc A. MD, PhD, Eric J. MD, Jennifer S. BSPH, Leah E. BA, Mary Ann MSN, Robert M. MD, Kevin A. MD, for the VALIANT Investigators for the VALIANT Investigators,